MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation

K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn (Nakhon Nayok, Thailand)

Meeting: 2022 International Congress

Abstract Number: 1478

Keywords: Constipation, Parkinsonism, Scales

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: This study aims to identify differences of constipation symptoms in detail by using the constipation scoring system between PD patients and non-PD patients.

Background: Constipation is the non-motor symptom that prevalent in Parkinson’s disease (PD) patients. It usually disturbs the quality of life and also has drawbacks on gut absorption. There is still no active therapy to solve this problem. Laxatives are just symptomatic support.

Method: This cross-sectional study included PD patients with constipation from the neurology clinic and non-PD patients with constipation from the gastrointestinal clinic. The baseline characteristics included levodopa equivalent dose (LED) and Hoehn and Yahr (H&Y) staging for PD patients, evaluation of the constipation scoring system, and knowledge of useful vegetables for constipation were obtained by either direct or telephone interviews. The statistical analysis was the Chi-square test

Results: One hundred and seventeen volunteers, 67 (57.27%) in the PD group, and 50 (42.73%) in the non-PD group were included. The mean age of the PD and the non-PD group is 71.38±10.88 and 65.10±15.64 years, orderly (p<0.05).  The mean duration of PD is 6.62±3.70 years. PD patients are in H&Y stage 2 at 74.6%, followed by stages 3, 1, 4, and 5 at 17.9%, 3.0%, 3.0%, and 1.5%, respectively. The mean LED is 861.97±384.33 mg/day. There was no statistical significance of gender, laxative use, combined laxative use, digit or maneuver assist, coffee drinking, smoking, alcohol consumption, exercise, and amount of water intake between two groups. The non-PD group had other gastrointestinal conditions more than the PD group (p<0.05), but some of patients in the PD group were documented dementia (p<0.01). Hyperlipidemia was common in the PD group (p<0.05). The analysis of characters of constipation revealed that PD patients have a longer duration of constipation than non-PD patients (p<0.001). In contrast, the frequency of bowel movement, painful evacuation effort, incompleteness, abdominal pain, minutes in lavatory per attempt, assistance, and failure for evacuation show no statistical significance. The laxative effect of zucchini, bitter gourd, bitter cucumber, and climbing wattle, was well known in non-PD patients (p<0.05).

Conclusion: PD patients with constipation had a history of longer duration of constipation than non-PD patients with constipation.

To cite this abstract in AMA style:

K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn. The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/the-comparison-of-constipation-scoring-system-scales-between-parkinsons-disease-and-non-parkinsons-disease-patients-with-constipation/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-comparison-of-constipation-scoring-system-scales-between-parkinsons-disease-and-non-parkinsons-disease-patients-with-constipation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley